Practice Test Geeks(CTR) Certified Tumor Registrar Practice Test
← All CTR Flashcard Decks

Abstracting & Coding Flashcards

7 cards from real CTR practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.

Read the first 7 Abstracting & Coding flashcards as text

  1. When abstracting a case with multiple primaries, which SEER rule determines whether two tumors in the same site are counted as one or two primaries?

    Answer: The Multiple Primary and Histology (MP/H) rules

    SEER's Multiple Primary and Histology (MP/H) rules govern whether tumors at the same site constitute one or multiple primaries.

  2. Which ICD-O-3 behavior code indicates an in-situ neoplasm?

    Answer: /2

    ICD-O-3 behavior code /2 denotes carcinoma in situ, meaning the tumor has not invaded surrounding tissue.

  3. A patient is diagnosed with lobular carcinoma in situ (LCIS) of the breast. Under current SEER guidelines, how should this be handled?

    Answer: Do not report; LCIS is not reportable under SEER

    LCIS is no longer considered a reportable malignancy under SEER guidelines because it is regarded as a risk factor, not a true in-situ cancer.

  4. When coding the histology of a tumor described as 'poorly differentiated adenocarcinoma,' which grade code is assigned?

    Answer: Grade 3

    Poorly differentiated tumors are assigned Grade 3 in the standard four-tier grading system used in cancer registries.

  5. Which field is used to record the first course of treatment that was planned and/or administered to the patient?

    Answer: First course of treatment

    The 'first course of treatment' field captures all planned and administered treatment from diagnosis through the initial treatment plan.

  6. A pathology report describes a tumor as 'transitional cell carcinoma.' What is the preferred ICD-O-3 histology code?

    Answer: 8120/3

    Transitional cell carcinoma (also called urothelial carcinoma) is coded 8120/3 in ICD-O-3.

  7. Under CoC standards, what is the required turnaround time for completing an abstract after the patient's first contact at the facility?

    Answer: 6 months

    The Commission on Cancer requires that abstracts be completed within 6 months of a patient's first contact at the reporting facility.

How this page was made: written with AI tools and published by Nathan Beja, founder of Practice Test Geeks, who is responsible for its content. Exam facts are checked against the official sources listed below. Not reviewed by a subject-matter expert. Editorial policy

Sources & references

Exam facts on this page (fees, format, dates, passing scores) are checked against these official sources; the date is our last check. Editorial policy

  1. ncra-usa.org — Renewal, eligibility, passing score, retake policy, score release, test dates, time limit, test delivery, fees, registration deadline · verified Oct 2026